Research and Development
Kite Pharma, Roche to co-develop two new treatments for non-hodgkin lymphoma
March 18, 2016 Medical Communications, Research and Development Gentech, Roche, kite pharma, non-Hodgkin lymphoma
FDA approves Breckenridge’s generic of Pfizer’s anti-epilepsy drug
March 18, 2016 Research and Development, Sales and Marketing FDA, Neurontin, Pfizer, anti-epilepsy, approval, breckenridge, gabapentin, tris pharma
Merck & Co says study shows significantly higher persistence for its arthritis drug Simponi
March 17, 2016 Research and Development, Sales and Marketing Merck & Co, drug trial, research, rheumatoid arthritis
Vitae Pharma soars on positive mid-stage trial results for psoriasis drug
March 17, 2016 Business Services, Research and Development, Sales and Marketing Vitae Pharmaceuticals, drug trial, psoriasis, research
FDA approves Bayer haemophilia A drug Kovaltry
March 17, 2016 Research and Development, Sales and Marketing Bayer, FDA, approval, drug, drug approval, haemophilia, haemophilia a, kovaltry, viii compound
Chugai receive orphan drug status for autoimmune disease treatment
March 17, 2016 Manufacturing and Production, Medical Communications, Research and Development chuagi, systemic scleroderma, tocilizumab
Sir Andrew Witty announces decision to step down as CEO of GSK
March 17, 2016 Medical Communications, Research and Development Andrew Witty, GSK, GlaxoSmithKline, Neil Woodford, Sir Andrew Witty, Witty, gsk break up, gsk split, retirement, steps down
GSK’s asthma drug meets primary goal in safety study for children
March 17, 2016 Research and Development Advair Diskus, GSK, asthma, drug trial
Amgen skin cancer drug Imlygic rejected by NICE
March 16, 2016 Research and Development Amgen, Imlygic, NICE, melanoma, skin cancer
Vectura agree £441m merger with Skyepharma
March 16, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Skyepharma, UK, biotech, merger, vectura
Vaxon Biotech completes enrollment for mid-stage trial of lung cancer vaccine
March 16, 2016 Research and Development, Sales and Marketing NSCLC, immuno-oncology, vaxon biotech
GSK establish cell and gene therapy collaboration with Miltenyi Biotec
March 16, 2016 Medical Communications, Research and Development GSK, GlaxoSmithKline, cell and gene therapy, collaboration, miltenyi biotec
Blueprint Medicines agrees $1 billion-plus deal with Roche for cancer therapy
March 16, 2016 Business Services, Research and Development, Sales and Marketing Blueprint Medicines, Deals, Immunokinases, Roche, drug development
New research supports association between Zika virus and microcephaly
March 16, 2016 Medical Communications, Research and Development Lancet, Zika virus, french polynesia, microcephaly, outbreak
PureTech’s Vedanta Biosciences appoints former Genzyme VP chief scientific officer
March 16, 2016 Medical Communications, Research and Development Bruce Roberts, Genzyme, Vedanta Biosciences
